Few reports revealed that NF-κB was activated in mesothelioma cells and the use of proteasome inhibitors or antitumor ribonuclease reagents was effective in controlling tumorigenic proliferation and inducing an apoptotic reaction through the prevention of NF-κB activity 21,22,25,26. This evidence concerns the gene NFKB1 and mesothelioma.